Destiny Hinton

New treatments have led to new thinking and new approaches to pediatric cancer – and sometimes, a cure isn’t the goal.

High science calls on Star Wars character as a potential ally against Alzheimer’s disease.

St. Jude is testing adult cancer drug prexasertib in children with recurrent or refractory medulloblastoma to inhibit checkpoint kinase chk1/2.

Hiroto Inaba: scientist, pediatric oncologist and "first son" of an old samurai family. His unfortunate enemy: childhood cancer.

A physician scientist updates the St. Jude model of research and clinical care, transforming clinical informatics.

An agreement between one U.S. hospital and two Chinese hospitals in 1991 has completely changed global pediatric cancer care.

Effective leukemia treatment is one thing – making sure it’s optimized with minimal implications is another. Read research juggles both to help patients.

Read how the discovery of this gene could change immunotherapy cancer and viral infection treatments.

You’re just out of cancer treatment – now what? Read about the transition oncology program that helps young cancer patients get back to living.

Stress granules form from heat shock to the cell then disappear, but when treated with an inhibitor to the protein ULK, the stress granules persist event after removal of the stress.